MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Antibody-drug conjugate SKB264 shows potential for durable responses in advanced gastric or gastroesophageal junction cancers.

Learn about the findings (CT038) presented by our Dr. Jordi Rodon at : bit.ly/3PVRLEU AACR (2/3)

Antibody-drug conjugate SKB264 shows potential for durable responses in advanced gastric or gastroesophageal junction cancers.

Learn about the findings (CT038) presented by our Dr. Jordi Rodon at #AACR24: bit.ly/3PVRLEU @AACR #EndCancer (2/3)
account_circle
Leonardo Ferreira(@enhancerleo) 's Twitter Profile Photo

My first research experience as an undergraduate Universidade de Coimbra focused on . Truly a treat to see Chi Van Dang speaking on his seminal discoveries on MYC and cancer metabolism AACR 2024!
sciencedirect.com/science/articl…

My first research experience as an undergraduate @UnivdeCoimbra focused on #cancer #metabolism. Truly a treat to see @ChiVanDang1 speaking on his seminal discoveries on MYC and cancer metabolism @AACR 2024! #endcancer #AACR2024 
sciencedirect.com/science/articl…
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Three MD Anderson researchers present novel targets and emerging therapeutic strategies at :

Dr. Paolo Strati discusses a novel combination with the CD47 blocker evorpacept for B-cell non-Hodgkin (CT037). bit.ly/3PVRLEU AACR (1/3)

Three MD Anderson researchers present novel targets and emerging therapeutic strategies at #AACR24:

Dr. Paolo Strati discusses a novel combination with the CD47 blocker evorpacept for B-cell non-Hodgkin #lymphoma (CT037). bit.ly/3PVRLEU @AACR #EndCancer (1/3)
account_circle
Leonardo Ferreira(@enhancerleo) 's Twitter Profile Photo

Fifth and final day of American Association for Cancer Research AACR 2024 in full swing with amazing talks, posters, vendors, reconnecting with old friends, and making new ones!

Fifth and final day of American Association for Cancer Research @AACR 2024 in full swing with amazing talks, posters, vendors, reconnecting with old friends, and making new ones! #AACR24 #endcancer #immunologymatters #changingwhatspossible
account_circle
Kelly Anderson(@kelly_archives) 's Twitter Profile Photo

That's incredibly promising news! The development of a pancreatic cancer vaccine that continues to offer protection against cancer recurrence for three years is a significant advancement. IT

account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

How does an antibiotic pre-conditioning regimen affect gut health and immunity in patients with advanced ?

Our Dr. Yongwoo David Seo shared findings (CT030) at : bit.ly/4cIDANr Y. David Seo MD Bella Glitza, MD, PhD Jennifer Wargo MD AACR

account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

New triple-negative breast cancer models help identify vulnerabilities in chemotherapy-resistant disease.

Our Dr. Amanda Rinkenbaugh shares findings (Abstract 6620) at : brnw.ch/21wIFuM AACR

New triple-negative breast cancer models help identify vulnerabilities in chemotherapy-resistant disease.

Our Dr. Amanda Rinkenbaugh shares findings (Abstract 6620) at #AACR24: brnw.ch/21wIFuM @AACR #BreastCancer #EndCancer
account_circle
Anne Tsao, MD, MBA(@AnneTsao2) 's Twitter Profile Photo

This really is one of the best things that you get to do as an academic physician - help support and grow our future leaders to change the world!

account_circle
Trevor Foreman(@trevor4man) 's Twitter Profile Photo

It’s a beautiful morning for a run. That’s why MD Anderson Cancer Center is sponsoring the Project Joy and Hope 5K/10K fun run, and handing out sunblock and cooling towels to all the runners.

It’s a beautiful morning for a run.  That’s why @MDAndersonNews is sponsoring the Project Joy and Hope 5K/10K fun run, and handing out sunblock and cooling towels to all the runners. #EndCancer
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Combining PARP and PI3K inhibitors shows encouraging results in a Phase Ib trial for molecularly selected patients, according to results presented by our Dr. Timothy Yap (Abstract CT042).

Read about this research: bit.ly/3PVRLEU AACR (3/3)

Combining PARP and PI3K inhibitors shows encouraging results in a Phase Ib trial for molecularly selected patients, according to results presented by our Dr. Timothy Yap (Abstract CT042).

Read about this research: bit.ly/3PVRLEU @AACR #AACR24 #EndCancer (3/3)
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

A study presented by Dr. Yun Seong Jeong identifies new gastric cancer consensus subtypes that are linked to patient outcomes.

Read about this research (Abstract 3930): brnw.ch/21wIEbH AACR

A study presented by Dr. Yun Seong Jeong identifies new gastric cancer consensus subtypes that are linked to patient outcomes. 

Read about this research (Abstract 3930): brnw.ch/21wIEbH @AACR #AACR24 #EndCancer
account_circle